Observational study / 2012
Patients with breast cancer showed impaired VO2peak across survivorship, and higher VO2peak was linked to lower risk of death in metastatic disease.
Cardiopulmonary exercise testing was used to evaluate VO2peak across four breast cancer cohorts totaling 248 women. Mean VO2peak was 17.8 ± 4.3 mL · kg(-1) · min(-1) (27% ± 17% below age-matched healthy sedentary women), and 32% had a VO2peak under 15.4 mL · kg(-1) · min(-1). VO2peak differed significantly across cohorts and was lowest in metastatic disease. In patients with metastatic disease (n = 52), achieving a VO2peak > 1.09 L · min(-1) was linked to an adjusted hazard ratio for death of 0.32 (95% CI, 0.16 to 0.67, P = .002) compared with a VO2peak ≤ 1.09 L · min(-1).
Shows an association, not proof of cause and effect.
- Study type
- Cross-sectional and prospective cohort study
- Who was studied
- 248 women (age 55 ± 8 years) across four breast cancer cohorts
- What was measured
- Peak oxygen consumption (VO2peak) and risk of death in metastatic disease
THE PAPER
Cardiopulmonary function and age-related decline across the breast cancer survivorship continuum.
Jones LW, Courneya KS, Mackey JR, Muss HB, Pituskin EN, Scott JM, Hornsby WE, Coan AD, Herndon JE, Douglas PS, Haykowsky M. J Clin Oncol, 2012.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.